Pipeline

Biotech Company Specialized in Regenerative Medicine
Development Stage

Development Stage

Development Stage
Pipeline Indication Discovery Nonclinical Phase I Phase II Phase III Approval/MA
Hutrigel®-RU Xeno-free alternative to Matrigel, Geltrex and so on
Hutrigel®-MU Peripheral nerve injury, Skin wound
Hutrigel®-AU Moderate to severe facial wrinkles and folds
BleeFix® Oozing-type bleeding following primary hemostasis
Under confirmatory clinical study
LifeLiver® (Bioartificial Liver Support System) Acute liver failure and acute-on-chronic liver failure under liver transplantation waiting list
Hair Cell Therapeutic Alopecia (baldness)
  • Hutrigel®-RU : Completed
  • Hutrigel®-MU : Under preparing for nonclinical study
  • Hutrigel®-AU : Under preparing for nonclinical study
  • BleeFix® (Hemostat) : Under confirmatory clinical study
  • LifeLiver® (Bioartificial Liver Support System) : Under P2b clinical study
  • Hair Cell Therapeutic : Under discovery, Linked with existing IP and Platform Technology